Orange Book product · Generic (ANDA)
DOXAZOSIN MESYLATE
DOXAZOSIN MESYLATE
At a glance
Jul 07, 2017
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jul 07, 2017
9 yr 1 mo ago
Today
Pharmaceutical detail
Active ingredient
DOXAZOSIN MESYLATE
Strength
EQ 1MG BASE
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 208719
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of DOXAZOSIN MESYLATE
- 2005CARDURA XLBrand (NDA)
NDA 021269 · VIATRIS
- 1990CARDURABrand (NDA)
NDA 019668 · VIATRIS
- 2024DOXAZOSIN MESYLATEGeneric (ANDA)
ANDA 212329 · UNICHEM
- 2022DOXAZOSIN MESYLATEGeneric (ANDA)
ANDA 212727 · RISING
- 2018DOXAZOSIN MESYLATEGeneric (ANDA)
ANDA 209013 · SOMERSET THERAPS LLC
- 2018DOXAZOSIN MESYLATEGeneric (ANDA)
ANDA 205210 · HERITAGE PHARMA
- 2014DOXAZOSIN MESYLATEGeneric (ANDA)
ANDA 202824 · ACCORD HLTHCARE
- 2004DOXAZOSIN MESYLATEGeneric (ANDA)
ANDA 076161 · STRIDES PHARMA INTL
- 2001DOXAZOSIN MESYLATEGeneric (ANDA)
ANDA 075750 · PLIVA
- 2001DOXAZOSIN MESYLATEGeneric (ANDA)
ANDA 075353 · TEVA
- 2000DOXAZOSIN MESYLATEGeneric (ANDA)
ANDA 075509 · AUROBINDO PHARMA USA
- 2000DOXAZOSIN MESYLATEGeneric (ANDA)
ANDA 075574 · ACTAVIS ELIZABETH
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
